Cargando…
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
The failure of several Phase II/III clinical trials in Alzheimer's disease (AD) with drugs targeting β-amyloid accumulation in the brain fuelled an increasing interest in alternative treatments against tau pathology, including approaches targeting tau phosphatases/kinases, active and passive im...
Autores principales: | Panza, Francesco, Solfrizzi, Vincenzo, Seripa, Davide, Imbimbo, Bruno P., Lozupone, Madia, Santamato, Andrea, Zecca, Chiara, Barulli, Maria Rosaria, Bellomo, Antonello, Pilotto, Alberto, Daniele, Antonio, Greco, Antonio, Logroscino, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939203/ https://www.ncbi.nlm.nih.gov/pubmed/27429978 http://dx.doi.org/10.1155/2016/3245935 |
Ejemplares similares
-
Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms
por: Panza, Francesco, et al.
Publicado: (2015) -
Nutrition, frailty, and Alzheimer's disease
por: Panza, Francesco, et al.
Publicado: (2014) -
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention
por: Panza, Francesco, et al.
Publicado: (2018) -
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
por: Vecchio, Filomena Lo, et al.
Publicado: (2022) -
CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series
por: Seripa, Davide, et al.
Publicado: (2018)